公司资料
Marinus 股价、新闻与催化剂
- 股票代码:
- MRNS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for MRNS.
公司概览
业务概览
Marinus is a neuroscience company focused on seizure and neuropsychiatric disorders with a commercial and development mix. Its story has been shaped by efforts to turn CNS programs into durable value.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Marinus sits in specialty neuroscience biopharma.
商业模式特征
The business depends on product adoption, pipeline progress, and the ability to stabilize a concentrated CNS story.
生物医药行业定位
Marinus is a catalyst-sensitive CNS name whose stock reacts to both commercial and clinical updates.
未来催化剂
- Marinus’s catalyst set is centered on ZTALMY and any strategic update that clarifies the company’s remaining value after the epilepsy program. The story is now more about what the company becomes next than about a broad pipeline.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。